Meeting Program & Speakers
The Westin New Orleans Canal Place
2012 New Directions in
Biology and Disease of Skeletal Muscle Conference
JUNE 17 - 21, 2012
New Orleans, Louisiana
Preliminary PROGRAM
10:00 am Registration 12:00 pm MDA Translational Research Symposium
Introduction
12:15 pm Academic Projects
- Translation in Academia
- Collaboratiing with Companies
- Starting Your Own CompanyTech Transfer - Getting the project out of the university IP - What is needed and when Break Working with the FDA Resources - Panel Discussion with
MVP / B21, NIH -NCATS, TACT, Pfizer drug database,
Other funding angenciesDeveloping a clinical trial protocol for muscle disease: Case Studies Break Industry Efforts Summary of session and messages learned 6:00 pm Opening Remarks and Introduction of Keynote Speaker
6:15 pm Keynote Speaker - Douglas C. Wallace, Ph.D., The Children's Hospital of Philadelphia and University of Pennsylvania
Mitochondrial Muscle Disease
7:00 pm 9:00 pm
Reception
Monday, June 18, 2012
Inflammation and Fibrosis - Chair: Melissa Spencer
8:00 am Kanneboyina Nagaraju, Ph.D., Children's National Medical Center
Inflammation in dysferlin deficiency
8:20 am Benedicte Chazaud, Ph.D., Universite Paris Descartes Role of macrophages in muscle Injury
8:40 am Jeff Molkentin, Ph.D., Cincinnati Children's Hospital p38 signaling defects in MD
9:00 am Pura Munoz Canoves, Ph.D., Universitat Pompeu Fabra Immune mediated mechanisms involved in development of fibrosis in mdx muscles
9:20 am Coffee 10:00 am Three Speakers TBN from Abstracts Muscle Growth and Regeneration - Chair: Elisabeth Barton 1:00 pm Grace Pavlath, Ph.D., Emory University
Satellite cells in muscle disease
1:20 pm Anton Bennett, Ph.D., Yale University 1:40 pm Markus Ruegg, Ph.D., Universitat Basel mTOR, hypertropy, congenital MD
2:00 pm Da-Zhi Wang, Ph.D., Children's Hospital Boston miRNAs and myogenesis
2:20 pm Break 3:00 pm Elizabeth Chen, PH.d., John Hopkins University Cystoskeletal rearrangement in myogenesis
3:20 pm Two Speakers TBN from Abstracts 5:00 pm Poster Session I
Tuesday, June 19, 2012
7:00 am Poster Session II Session III
Trafficking Defects in Muscle Diesease - Chair Alan Beggs
10:00 am Renzi Han, Loyola University 10:20 am Jocelyn Laporte, IGBMC Myotubularin in muscle disease
10:40 am Ning Lui, Ph.D., UT Southwestern Dynamin in muscle disease
11:00 am Melissa Spencer, Ph.D., UCLA Calpain mediate muscular dystrophy
11:20 am Three Speakers TBN from Abstracts Nuclear Defects - Chair: Laura Ranum Maurice Swanson, Ph.D., University of Florida MBNL2
Stephen Tapscott, MD, PhD, Fred Hutchinson Cancer Research Center, University of Washington FSH
Silvere van der Maarel Ph.D., Leiden University Medical Center
FSHD
Laura Ranum, Ph.D., University of Florida
Myotonic dystrophy
Break Three Speakers TBN from Abstracts
Wednesday, June 20, 2012
Signaling Defects and Therapies - Chair: Jill Rafael Fortney 8:00 am Kathryn Wagner, MD, PhD, Kennedy Krieger Institute, John Hopkins University Role of myostatin in fibrosis
8:20 am Dennis Guttridge, Ph.D., Ohio State University NF-KB signaling in MD
8:40 am Ronald Victor, M.D., Cedars-Sinai PDE5 inhibition in MD
9:00 am Dean Burkin, Ph.D., University of Nevada AKT signaling in MD
9:20 am Break 10:00 am Three Speakers TBN from Abstracts Gene Correction/Replacement and Novel Therapeutics -
Chairs: Kathryn Wagner and Volker Straub
1:00 pm Anna Buj-Bello, Ph.D., Genethon AAV for myotubular myopathy
1:20 pm - Francesco Muntoni, M.D., UCL Exon skipping in DMD
1:40 pm - Davide Gabellini,Ph.D., San Raffeale AAV for FSHD
2:00 pm -
Charles Thornton, M.D., University Rochester Medical Center
Myotonic Dystrophy Type 1
2:20 pm - Break 3:00 pm - Three Speakers TBN from Abstracts 6:30 pm - Riverboat Cruise
Thursday, June 21, 2012
8:00 am
Last update 2/07/2012
